Previous 10 | Next 10 |
- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pi...
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's preliminary fiscal fourth-quarter 2019 operating and financial highligh...
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that Chief Med...
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31 st Annual ROTH Conference, being held in Laguna Niguel, Ca. from March 17-19, 2019. Th...
In this article, we highlight what we believe are ties between Corbus Pharmaceutical Holdings ( CRBP ) and a group of suspect investors that were involved during the company’s IPO. In addition, we believe lenabasum has a history of negative clinical data, and we believe that lenabasum i...
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that its board ...
TORONTO, ON / ACCESSWIRE / February 13, 2019 / The Wealthy Venture Capitalist (or "WVC"), an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known biotech and pharma stocks making news and subsequent market moves, highlights how the pr...
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fiserv, Inc. (NASDAQ:FISV), DTE Energy Company (NYSE:DTE), Acacia Communi...
Organovo Holdings, Inc. (ONVO) Q3 2019 Results Earnings Conference Call February 07, 2019, 05:00 PM ET Company Participants Steve Kunszabo - Head-IR Taylor Crouch - CEO Craig Kussman - CFO Conference Call Participants Ed Arce - H.C. Wainwright Yasmeen Rahimi - ROTH Capita...
Organovo (NASDAQ: ONVO ) fiscal Q3 results ($M): Revenues: 0.8 (-32.4%). More news on: Organovo Holdings, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Organovo Holdings Inc. Company Name:
ONVO Stock Symbol:
NASDAQ Market:
Organovo Holdings Inc. Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that Executive Chairman Keith Murphy presen...